A phase II study of CBDCA and TS-1 in patients with advanced non-small cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2014
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Mar 2009 New trial record.